Published in Nat Clin Pract Rheumatol on July 01, 2006
Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage (2012) 1.96
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
The basic science of articular cartilage: structure, composition, and function. Sports Health (2009) 1.77
Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther (2008) 1.75
Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis. Arthritis Res Ther (2012) 1.74
What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles? J Am Acad Orthop Surg (2008) 1.33
Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers. Tissue Eng Part A (2010) 1.20
Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med (2009) 1.20
Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med (2012) 1.19
Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol (2014) 1.12
Concepts in gene therapy for cartilage repair. Injury (2008) 1.08
Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res (2011) 1.06
Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs. Cytotherapy (2012) 1.05
Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor. J Surg Res (2008) 1.03
Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Tissue Eng Part A (2009) 1.02
Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther (2010) 1.00
In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry. Biomaterials (2008) 1.00
A second-generation autologous chondrocyte implantation approach to the treatment of focal articular cartilage defects. Arthritis Res Ther (2007) 0.97
Mesenchymal stem cell-based tissue engineering for chondrogenesis. J Biomed Biotechnol (2011) 0.93
Low dose native type II collagen prevents pain in a rat osteoarthritis model. BMC Musculoskelet Disord (2013) 0.88
Stem cell application for osteoarthritis in the knee joint: A minireview. World J Stem Cells (2014) 0.87
TGF-ß1 enhances the BMP-2-induced chondrogenesis of bovine synovial explants and arrests downstream differentiation at an early stage of hypertrophy. PLoS One (2013) 0.87
Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: a case series. Clin Med Insights Arthritis Musculoskelet Disord (2013) 0.86
Three-dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases. Exp Biol Med (Maywood) (2014) 0.86
Single cell sorting identifies progenitor cell population from full thickness bovine articular cartilage. Osteoarthritis Cartilage (2014) 0.84
Covalently tethered TGF-β1 with encapsulated chondrocytes in a PEG hydrogel system enhances extracellular matrix production. J Biomed Mater Res A (2014) 0.84
Stem cell applications in military medicine. Stem Cell Res Ther (2011) 0.83
Nanostructured 3D constructs based on chitosan and chondroitin sulphate multilayers for cartilage tissue engineering. PLoS One (2013) 0.83
Dielectric study of the adhesion of mesenchymal stem cells from human umbilical cord on a sugarcane biopolymer. J Mater Sci Mater Med (2013) 0.82
In vitro cartilage tissue engineering using adipose-derived extracellular matrix scaffolds seeded with adipose-derived stem cells. Tissue Eng Part A (2011) 0.81
Supermacroporous poly(vinyl alcohol)-carboxylmethyl chitosan-poly(ethylene glycol) scaffold: an in vitro and in vivo pre-assessments for cartilage tissue engineering. J Mater Sci Mater Med (2013) 0.80
Enhanced chondrogenic differentiation of embryonic stem cells by coculture with hepatic cells. Stem Cells Dev (2008) 0.79
Combined effect of three types of biophysical stimuli for bone regeneration. Tissue Eng Part A (2014) 0.79
Three-dimensional osteochondral microtissue to model pathogenesis of osteoarthritis. Stem Cell Res Ther (2013) 0.79
Anti-inflammatory strategies in cartilage repair. Tissue Eng Part B Rev (2014) 0.78
Functional cartilage repair capacity of de-differentiated, chondrocyte- and mesenchymal stem cell-laden hydrogels in vitro. Osteoarthritis Cartilage (2014) 0.78
MicroRNA expression profiles in human adipose-derived stem cells during chondrogenic differentiation. Int J Mol Med (2014) 0.78
Extracellular Calcium Modulates Chondrogenic and Osteogenic Differentiation of Human Adipose-Derived Stem Cells: A Novel Approach for Osteochondral Tissue Engineering Using a Single Stem Cell Source. Tissue Eng Part A (2015) 0.78
Electrospinning covalently cross-linking biocompatible hydrogelators. Polymer (Guildf) (2012) 0.77
Silicon substrate as a novel cell culture device for myoblast cells. J Biomed Sci (2014) 0.77
Hyaluronan and synovial joint: function, distribution and healing. Interdiscip Toxicol (2013) 0.77
PD98059-impregnated functional PLGA scaffold for direct tissue engineering promotes chondrogenesis and prevents hypertrophy from mesenchymal stem cells. Tissue Eng Part A (2013) 0.76
Three dimensional de novo micro bone marrow and its versatile application in drug screening and regenerative medicine. Exp Biol Med (Maywood) (2015) 0.75
Protease inhibitors enhance extracellular collagen fibril deposition in human mesenchymal stem cells. Stem Cell Res Ther (2015) 0.75
Evaluation of the ability of natural and synthetic scaffolds in providing an appropriate environment for growth and chondrogenic differentiation of adipose-derived mesenchymal stem cells. Indian J Orthop (2015) 0.75
Propyl gallate inhibits adipogenesis by stimulating extracellular signal-related kinases in human adipose tissue-derived mesenchymal stem cells. Mol Cells (2015) 0.75
Human Articular Chondrocytes Regulate Immune Response by Affecting Directly T Cell Proliferation and Indirectly Inhibiting Monocyte Differentiation to Professional Antigen-Presenting Cells. Front Immunol (2016) 0.75
The genome of the largest bony fish, ocean sunfish (Mola mola), provides insights into its fast growth rate. Gigascience (2016) 0.75
A preclinical evaluation of an autologous living hyaline-like cartilaginous graft for articular cartilage repair: a pilot study. Sci Rep (2015) 0.75
Neoproteoglycans in tissue engineering. FEBS J (2013) 0.75
Xiphoid process-derived chondrocytes: a novel cell source for elastic cartilage regeneration. Stem Cells Transl Med (2014) 0.75
Low-Intensity Ultrasound (LIUS) as an Innovative Tool for Chondrogenesis of Mesenchymal Stem Cells (MSCs). Organogenesis (2007) 0.75
Tissue engineered strategies for skeletal muscle injury. Stem Cells Int (2011) 0.75
Regeneration of hyaline cartilage promoted by xenogeneic mesenchymal stromal cells embedded within elastin-like recombinamer-based bioactive hydrogels. J Mater Sci Mater Med (2017) 0.75
Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res (2002) 4.71
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (2007) 3.97
Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells (2007) 3.79
Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem (2004) 2.71
Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am (2011) 2.37
Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J (2004) 2.30
Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem (2003) 2.25
Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res (2002) 2.18
Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials (2005) 2.18
Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater (2006) 2.14
Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A (2003) 2.07
Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A (2010) 2.06
Transient exposure to transforming growth factor beta 3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-engineered cartilage. Tissue Eng Part A (2008) 1.95
Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol (2002) 1.90
Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells (2014) 1.89
Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng Part B Rev (2009) 1.88
Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage (2004) 1.87
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum (2008) 1.83
Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells (2003) 1.82
Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells (2006) 1.78
MicroRNAs and cell differentiation in mammalian development. Birth Defects Res C Embryo Today (2006) 1.78
Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther (2008) 1.75
iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev (2010) 1.73
Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol (2010) 1.68
Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol (2008) 1.67
Mechanoactive tenogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A (2008) 1.63
Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol (2006) 1.59
Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng (2006) 1.54
Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem (2007) 1.52
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther (2012) 1.48
Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem (2009) 1.47
Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol (2007) 1.46
Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell-laden cartilage constructs in a density-dependent manner. Tissue Eng Part A (2009) 1.43
Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng (2004) 1.34
Stem/progenitor cells from inflamed human dental pulp retain tissue regeneration potential. Regen Med (2010) 1.32
Regional multilineage differentiation potential of meniscal fibrochondrocytes: implications for meniscus repair. Anat Rec (Hoboken) (2007) 1.30
Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J Cell Biochem (2004) 1.30
Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am (2008) 1.28
Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials (2012) 1.28
Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem (2007) 1.27
Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev Dyn (2002) 1.27
Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells (2006) 1.26
Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem (2002) 1.25
Detection of periprosthetic infections with use of ribosomal RNA-based polymerase chain reaction. J Bone Joint Surg Am (2010) 1.23
Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev (2010) 1.22
Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol (2008) 1.22
Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res (2009) 1.22
Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs (2010) 1.21
Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A (2008) 1.20
Effects of TGF-beta1 and triiodothyronine on cartilage maturation: in vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res (2006) 1.20
Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res (2009) 1.20
Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med (2012) 1.19
Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med (2011) 1.19
Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials (2012) 1.18
Current state of cartilage tissue engineering. Arthritis Res Ther (2003) 1.17
Intervertebral disc cell response to dynamic compression is age and frequency dependent. J Orthop Res (2009) 1.16
Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res Ther (2010) 1.16
In vivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. Tissue Eng (2005) 1.14
Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol (2011) 1.14
Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol (2010) 1.14
Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today (2009) 1.13
Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model. Spine (Phila Pa 1976) (2002) 1.12
Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev (2010) 1.10
Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res (2003) 1.10
Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study. J Tissue Eng Regen Med (2009) 1.10
Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty (2004) 1.08
Concepts in gene therapy for cartilage repair. Injury (2008) 1.08
Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem (2009) 1.08
Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem (2002) 1.08
A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol (2003) 1.07
In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng (2002) 1.07
Stemming cartilage degeneration: adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthritis Rheum (2006) 1.07
Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res (2002) 1.07
TGF-beta1 calcium signaling in osteoblasts. J Cell Biochem (2007) 1.06
Adult mesenchymal stem cells: biological properties, characteristics, and applications in maxillofacial surgery. J Oral Maxillofac Surg (2007) 1.06
Spatiotemporal protein distribution of TGF-betas, their receptors, and extracellular matrix molecules during embryonic tendon development. Dev Dyn (2008) 1.06
Repair of porcine articular cartilage defect with a biphasic osteochondral composite. J Orthop Res (2007) 1.05
Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation. J Cell Biochem (2009) 1.04
Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther (2014) 1.04
Tissue engineering with mesenchymal stem cells. IEEE Eng Med Biol Mag (2003) 1.03
Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor. J Surg Res (2008) 1.03
Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol (2005) 1.03
CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J Cell Biol (2004) 1.03
A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum (2009) 1.03
Transient differentiation of adult human bone marrow cells into neuron-like cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms. Stem Cells Dev (2004) 1.01
Repair of porcine articular cartilage defect with autologous chondrocyte transplantation. J Orthop Res (2005) 1.01
Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today (2003) 1.01
Enhancement of tenogenic differentiation of human adipose stem cells by tendon-derived extracellular matrix. Biomaterials (2013) 1.01
Application of visible light-based projection stereolithography for live cell-scaffold fabrication with designed architecture. Biomaterials (2012) 1.00
Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther (2010) 1.00
Long-term in vitro analysis of limb cartilage development: involvement of Wnt signaling. J Cell Biochem (2004) 1.00
Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther (2012) 0.99
Cartilage oligomeric matrix protein enhances matrix assembly during chondrogenesis of human mesenchymal stem cells. J Cell Biochem (2012) 0.99
Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev (2005) 0.99
Human osteoblast-like cells in three-dimensional culture with fluid flow. Biorheology (2003) 0.99
Differential regulation of osteogenic marker gene expression by Wnt-3a in embryonic mesenchymal multipotential progenitor cells. Differentiation (2004) 0.99
Alterations in the spatiotemporal expression pattern and function of N-cadherin inhibit cellular condensation and chondrogenesis of limb mesenchymal cells in vitro. J Cell Biochem (2002) 0.98